Stock Earnings

Question 1

Báo cáo tài chính chính của Hangzhou Tigermed Consulting Co Ltd là gì?

Accepted Answer

Theo báo cáo tài chính mới nhất (Form-10K), Hangzhou Tigermed Consulting Co Ltd có tổng tài sản là $28,671, lợi nhuận ròng profit là $405

Question 2

Tỷ lệ tài chính chính của HNGZY là gì?

Accepted Answer

Tỷ lệ thanh khoản của Hangzhou Tigermed Consulting Co Ltd là 3.58, tỷ suất lợi nhuận ròng là 6.13, doanh thu trên mỗi cổ phiếu là $7.65.

Question 3

Doanh thu của Hangzhou Tigermed Consulting Co Ltd được phân bổ theo phân khúc hoặc khu vực địa lý như thế nào?

Accepted Answer

Hangzhou Tigermed Consulting Co Ltd largest revenue segment is Clinical Trial Technical Services, at a revenue of 4,168,128,309 in the most earnings release.For geography, China is the primary market for Hangzhou Tigermed Consulting Co Ltd, at a revenue of 4,234,516,020.

Question 4

Hangzhou Tigermed Consulting Co Ltd có lợi nhuận không?

Accepted Answer

yes, theo báo cáo tài chính mới nhất, Hangzhou Tigermed Consulting Co Ltd có lợi nhuận ròng profit là $405

Question 5

Hangzhou Tigermed Consulting Co Ltd có nợ không?

Accepted Answer

yes, Hangzhou Tigermed Consulting Co Ltd có nợ là 8,000

Question 6

Hangzhou Tigermed Consulting Co Ltd có bao nhiêu cổ phiếu đang lưu hành?

Accepted Answer

Hangzhou Tigermed Consulting Co Ltd có tổng cộng 861.29 cổ phiếu đang lưu hành

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	6,561	6,603	7,384	7,085	5,213	3,192
Revenue Growth (YoY)	-4%	-11%	4%	36%	63%	14%
Cost of Revenue	4,855	4,358	4,538	4,277	2,942	1,678
Gross Profit	1,706	2,244	2,845	2,808	2,270	1,514
Selling, General & Admin	965	860	782	722	652	435
Research & Development	257	229	254	229	211	151
Operating Expenses	1,174	1,154	1,132	1,028	841	557
Other Non Operating Income (Expenses)	-8	0	1	2	-12	-4
Pretax Income	800	664	2,488	2,585	3,684	2,218
Income Tax Expense	163	216	338	313	292	189
Net Income	612	405	2,024	2,006	2,874	1,749
Net Income Growth	-36%	-80%	1%	-30%	64%	108%
Shares Outstanding (Diluted)	868.8	863.04	865.32	864.89	870.95	799
Shares Change (YoY)	0%	0%	0%	-1%	9%	7%
EPS (Diluted)	0.7	0.46	2.34	2.32	3.3	2.19
EPS Growth	-36%	-80%	1%	-30%	51%	94%
Free Cash Flow	1,005	740	836	908	1,055	842
Free Cash Flow Per Share	1.15	0.85	0.96	1.04	1.21	1.05
Gross Margin	26%	33.98%	38.52%	39.63%	43.54%	47.43%
Operating Margin	8.09%	16.49%	23.18%	25.1%	27.41%	29.94%
Profit Margin	9.32%	6.13%	27.41%	28.31%	55.13%	54.79%
Free Cash Flow Margin	15.31%	11.2%	11.32%	12.81%	20.23%	26.37%
EBITDA	--	1,241	1,838	1,889	1,500	1,013
EBITDA Margin	--	18.79%	24.89%	26.66%	28.77%	31.73%
D&A For EBITDA	--	152	126	110	71	57
EBIT	531	1,089	1,712	1,779	1,429	956
EBIT Margin	8.09%	16.49%	23.18%	25.1%	27.41%	29.94%
Effective Tax Rate	20.37%	32.53%	13.58%	12.1%	7.92%	8.52%

Hangzhou Tigermed Consulting Co Ltd (HNGZY) Price

HNGZY Stock Price Chart

HNGZY Income

Follow-Up Questions